// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Late Breaking Abstract - Complication rates for bronchoscopy procedures performed at a large UK tertiary teaching hospital

Elinor Crisp - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Usefulness of topical Mitomycin C application via rigid bronchoscopy in the management of tracheal stenosis

Asad Anwar - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

mitomycin

Ambulatory pneumothorax with 8FG Rocket® Pleural Vent™ : setting up a service and probable safety in secondary pneumothoraces

Avinash Aujayeb - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pneumothorax

N/A

Utility of ultrasound-guided pleural biopsy in guiding treatment for malignant pleural disease

Vineeth George - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Indwelling pleural catheters for refractory transudative effusions: a tertiary centre experience

Vineeth George - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Chest drain insertion documentation: if it wasn’t written it didn’t happen

Mphatso Wirima - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A single centre’s real world experience with Rocket® Pleural Vent™ for treating pneumothorax

Michael Ball - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pneumothorax

N/A

Towards personalized lung cancer CT screening in Europe

Carlijn Van der Aalst - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Lung cancer screening - what does it mean for our practice?

Claire Calderwood - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Evaluating the outcomes of patients with haemoptysis referred to two rapid-access lung cancer clinics in the UK

Jonathan Noble - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Rationalising the lung cancer diagnostic pathway with CT triage; a single centre UK experience

Eleanor Barton - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The role of a dedicated chest x-ray reporting tool in the lung cancer diagnostic pathway

Helen Mcdill - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The travel burden for patients diagnosed with lung cancer at a District General Hospital in South East London

Poppy Denniston - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Route of referral correlates to lung cancer stage and with outcomes at a District General Hospital in South East London

Poppy Denniston - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

RAPID lung cancer diagnostic and care pathway from referral to treatment

Adnan Amir - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Transforming the Portsmouth Hospitals Lung Cancer Pathway (LCP

Lauren Fox - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Factors associated with lung cancer in patients referred to a fast-track clinic

Helen Mcdill - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Our experience and outcomes following indwelling pleural catheter (IPC insertion at the University Hospital Coventry and Warwickshire (UHCW and the effect of primary tumour site on outcomes

Viren Ahluwalia - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the role of pleural fluid in current cancer diagnostic pathway

Catherine Doig - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

The gendered Experience of mesothelioma study (GEMS: findings from a survey data analysis

Michaela Senek - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Copyright © 2026. QuantiNova All rights reserved